Clinical Trials Browser

Phase 2/3 × Propranolol × Dermatologic × Clear all

NCT02962947 2016-11-15

MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

Phase 2/3 Unknown

Melanoma